Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stattin

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
The Prostate|June 9, 2001
Gonadotropin-releasing hormone receptor expression in the human prostateTieva A, P Stattin, P Wikström, et al.
European Urology|January 1, 1996
p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancerP Stattin, A Bergh, L Karlberg, et al.
The Prostate|August 28, 1998
Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancerP Wikström, P Stattin, I Franck-Lissbrant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2010
Dietary supplement use patterns in men with prostate cancer: the Cancer Prostate Sweden studyA Westerlund, G Steineck, K Bälter, et al.
Scandinavian Journal of Urology and Nephrology|June 20, 2001
Circulating insulin-like growth factor-I and benign prostatic hyperplasia--a prospective studyP Stattin, R Kaaks, E Riboli, et al.
European Journal of Clinical Pharmacology|May 8, 2012
Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe SwedenB Grundmark, H Garmo, B Zethelius, et al.
European Journal of Clinical Nutrition|May 27, 2010
Validity of food frequency questionnaire estimated intakes of folate and other B vitamins in a region without folic acid fortificationI Johansson, B Van Guelpen, J Hultdin, et al.
Scandinavian Journal of Urology and Nephrology|November 30, 2000
Evaluation of prognostic factors in prostate cancer with partial least squares analysisP Wikström, P Wikström, I F Lissbrant, et al.
International Journal of Oncology|August 12, 2000
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survivalI F Lissbrant, P Stattin, P Wikstrom, et al.
Scandinavian Journal of Urology and Nephrology|April 9, 2001
p53 expression in correlation to clinical outcome in patients with renal cell carcinomaB Ljungberg, B Bozoky, G Kovacs, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Prostate|June 9, 2001
Gonadotropin-releasing hormone receptor expression in the human prostateTieva A, P Stattin, P Wikström, et al.
European Urology|January 1, 1996
p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancerP Stattin, A Bergh, L Karlberg, et al.
The Prostate|August 28, 1998
Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancerP Wikström, P Stattin, I Franck-Lissbrant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2010
Dietary supplement use patterns in men with prostate cancer: the Cancer Prostate Sweden studyA Westerlund, G Steineck, K Bälter, et al.
Scandinavian Journal of Urology and Nephrology|June 20, 2001
Circulating insulin-like growth factor-I and benign prostatic hyperplasia--a prospective studyP Stattin, R Kaaks, E Riboli, et al.
European Journal of Clinical Pharmacology|May 8, 2012
Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe SwedenB Grundmark, H Garmo, B Zethelius, et al.
European Journal of Clinical Nutrition|May 27, 2010
Validity of food frequency questionnaire estimated intakes of folate and other B vitamins in a region without folic acid fortificationI Johansson, B Van Guelpen, J Hultdin, et al.
Scandinavian Journal of Urology and Nephrology|November 30, 2000
Evaluation of prognostic factors in prostate cancer with partial least squares analysisP Wikström, P Wikström, I F Lissbrant, et al.
International Journal of Oncology|August 12, 2000
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survivalI F Lissbrant, P Stattin, P Wikstrom, et al.
Scandinavian Journal of Urology and Nephrology|April 9, 2001
p53 expression in correlation to clinical outcome in patients with renal cell carcinomaB Ljungberg, B Bozoky, G Kovacs, et al.
Pageof 6